Fece de la Cruz Ferran - CeMM - Research Center for Molecular Medicine of the Austrian Academy of Sciences, A1090 Vienna, Austria; email: snijman@cemm.oeaw.ac.at.

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 29 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract LB449: Strategies to overcome resistance to PI3Kalpha-selective inhibitors mediated by acquired alterations in the PI3K/AKT pathway

Ferran Fece de la Cruz,Andreas Varkaris,Elizabeth E. Martin, Bryanna L. Norden, Nicholas Chevalier, Allison M. Kehlmann,Ignaty Leshchiner,Haley Barnes, Sara Ehnstrom, Parasvi Patel, Janice S. Kim,Haley Ellis,

Cancer Researchno. 7_Supplement (2024)

引用0浏览0引用

Sotorasib is a pan-RASG12C inhibitor capable of driving clinical response in NRASG12C cancers

Douglas A Rubinson, Noritaka Tanaka,Ferran Fece de la Cruz,Kevin S Kapner,Michael H Rosenthal, Bryanna L Norden,Haley Barnes, Sara Ehnstrom, Alvin A Morales-Giron,Lauren K Brais, Christopher T Lemke,Andrew J Aguirre,

Cancer discovery (2024)

引用0浏览0WOS引用

Allosteric PI3K Inhibition Overcomes On-target Resistance to Orthosteric Inhibitors Mediated by Secondary PIK3CA Mutations

Andreas Varkaris,Ferran Fece de la Cruz,Elizabeth E. Martin, Bryanna L. Norden, Nicholas Chevalier, Allison M. Kehlmann,Ignaty Leshchiner,Haley Barnes, Sara Ehnstrom, Anastasia-Maria Stavridi,Xin Yuan, Janice S. Kim,

CANCER DISCOVERY（2024）

引用1浏览0WOS引用

Landscape of Clinical Resistance Mechanisms to FGFR Inhibitors in FGFR2-Altered Cholangiocarcinoma

Qibiao Wu,Haley Ellis,Giulia Siravegna, Alexa G Michel, Bryanna L Norden,Ferran Fece de la Cruz, Eranga Roshan Balasooriya,Yuanli Zhen, Vanessa S Silveira, Jianwe Che,Ryan B Corcoran,Nabeel Bardeesy

Clinical cancer research : an official journal of the American Association for Cancer Researchno. 1 (2024): 198-208

引用0浏览0WOS引用

Abstract LB366: KRASG12C inhibition enhances immunogenicity in KRASG12C-mutant colorectal cancer

Parasvi S. Patel, Jun Tian,Ferran Fece de la Cruz, Jacquelyn Curtis, Apekshya Panda,Tomonori Oka,Shadmehr Demehri,Moshe Sade-Feldman, Scott Koptez,Ryan B. Corcoran

Cancer Researchno. 7_Supplement (2024)

引用0浏览0引用

Supplemental Figure S3 from Co-occurring Alterations in the RAS–MAPK Pathway Limit Response to MET Inhibitor Treatment in MET Exon 14 Skipping Mutation-Positive Lung Cancer

Julia Rotow,Philippe Gui,Wei Wu,Victoria M. Raymond,Richard B. Lanman,Frederic J. Kaye,Nir Peled,Ferran Fece de la Cruz,Brandon Nadres,Ryan B. Corcoran,Iwei Yeh,Boris C. Bastian,

openalex（2023）

引用0浏览0引用

Abstract LB352: KRAS inhibition enhances immunogenicity of KRASG12C colorectal cancer

Jiajun Tian,Ferran Fece de la Cruz,Kelly P. Burke, Tomonori Oka, Jacquelyn M. Curtis,Princy Sindurakar,Edmond Wong,Shadmehr Demehri,Arlene H. Sharpe,Ryan B. Corcoran

Cancer Researchno. 8_Supplement (2023): LB352-LB352

引用0浏览0引用

Data from Vertical Pathway Inhibition Overcomes Adaptive Feedback Resistance to KRAS^G12C Inhibition

Meagan B. Ryan,Ferran Fece de la Cruz, Sarah Phat, David T. Myers,Edmond Wong,Heather A. Shahzade, Catriona B. Hong,Ryan B. Corcoran

openalex（2023）

引用0浏览0引用

KRAS inhibition enhances immunogenicity of KRAS^G12C colorectal cancer

Jun Tian,Ferran Fece de la Cruz,Kelly Burke,Tomonori Oka, Jacquelyn M. Curtis,Princy Sindurakar,Edmond Wong,Shadmehr Demehri,Arlene Sharpe,Ryan Corcoran

CANCER RESEARCHno. 8 (2023)

引用0浏览0引用

Data from TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion–Positive Intrahepatic Cholangiocarcinoma

Lipika Goyal,Lei Shi, Leah Y. Liu,Ferran Fece de la Cruz,Jochen K. Lennerz,Srivatsan Raghavan, Ignaty Leschiner,Liudmila Elagina,Giulia Siravegna,Raymond W.S. Ng,Phuong Vu,Krushna C. Patra,

crossref（2023）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn